Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
暂无分享,去创建一个
[1] Shanta M. Messerli,et al. 4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma , 2017, Brain sciences.
[2] James M. Murphy,et al. The secret life of kinases: insights into non-catalytic signalling functions from pseudokinases. , 2017, Biochemical Society transactions.
[3] Xin Hu,et al. PTK7 is a novel oncogenic target for esophageal squamous cell carcinoma , 2017, World Journal of Surgical Oncology.
[4] Etienne Z. Gnimpieba,et al. Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors , 2017, Molecular Cancer Research.
[5] Jeffrey T Leek,et al. Reproducible RNA-seq analysis using recount2 , 2017, Nature Biotechnology.
[6] A. Wodarz,et al. PTK7 Faces the Wnt in Development and Disease , 2017, Front. Cell Dev. Biol..
[7] Samuel A. Williams,et al. A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions , 2017, Science Translational Medicine.
[8] Won-Sik Shin,et al. Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells , 2016, Oncotarget.
[9] T. Park,et al. LPEseq: Local-Pooled-Error Test for RNA Sequencing Experiments with a Small Number of Replicates , 2016, PloS one.
[10] Xiu-Yun Tian,et al. PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance , 2016, Oncology reports.
[11] J. Borg,et al. The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway* , 2015, The Journal of Biological Chemistry.
[12] Won-Sik Shin,et al. Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis. , 2015, Biochimica et biophysica acta.
[13] J. Borg,et al. Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer , 2015, PloS one.
[14] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[15] Yongxiang Yin,et al. PTK7 protein is decreased in epithelial ovarian carcinomas with poor prognosis. , 2014, International journal of clinical and experimental pathology.
[16] Ji-Hee Kim,et al. Protein tyrosine kinase 7 plays a tumor suppressor role by inhibiting ERK and AKT phosphorylation in lung cancer. , 2014, Oncology reports.
[17] H. Ryu,et al. High Expression of Protein Tyrosine Kinase 7 Significantly Associates with Invasiveness and Poor Prognosis in Intrahepatic Cholangiocarcinoma , 2014, PloS one.
[18] Jun Qin,et al. A robust methodology to subclassify pseudokinases based on their nucleotide-binding properties. , 2014, The Biochemical journal.
[19] D. Frank,et al. PTK7 modulates Wnt signaling activity via LRP6 , 2014, Development.
[20] Won-Sik Shin,et al. Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma , 2013, Cancer science.
[21] Claudia Baumann,et al. Tyrosine kinase expression profile in clear cell renal cell carcinoma , 2012, World Journal of Urology.
[22] N. Tolwinski,et al. PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling , 2011, The EMBO journal.
[23] Li-Xuan Qin,et al. Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis. , 2011, Cancer research.
[24] F. Puppo,et al. Protein tyrosine kinase 7 has a conserved role in Wnt/β‐catenin canonical signalling , 2011, EMBO reports.
[25] D. Shangguan,et al. Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway , 2010, PloS one.
[26] F. Puppo,et al. The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcome. , 2010, Blood.
[27] I. Shnitsar,et al. PTK7 recruits dsh to regulate neural crest migration , 2008, Development.
[28] Jae-Won Jung,et al. Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. , 2008, Biochemical and biophysical research communications.
[29] M. Tessier-Lavigne,et al. PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates , 2004, Nature.
[30] Michael A. Choti,et al. A Phosphatase Associated with Metastasis of Colorectal Cancer , 2001, Science.
[31] R. Spritz,et al. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma , 1997, International journal of cancer.
[32] H. Lee,et al. Characterization of the human full-length PTK7 cDNA encoding a receptor protein tyrosine kinase-like molecule closely related to chick KLG. , 1996, Journal of biochemistry.
[33] A. Ullrich,et al. Colon carcinoma kinase-4 defines a new subclass of the receptor tyrosine kinase family. , 1995, Oncogene.
[34] R. Spritz,et al. A survey of protein tyrosine kinase mRNAs expressed in normal human melanocytes. , 1993, Oncogene.
[35] J. Luketich,et al. Oesophageal carcinoma , 2013, The Lancet.
[36] A. Jemal,et al. Global Cancer Statistics , 2011 .